NCT01390324View on ClinicalTrials.gov

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
MigraineHeadache
Interventions
DRUG

Fixed-dose combination of naratriptan+naproxen

Tablets containing naratriptan 2,5 mg + naproxen 500 mg

DRUG

Naratriptan

Tablets containing naratriptan 2,5 mg

DRUG

Naproxen

Tablets containing naproxen 500 mg

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY

NCT01390324 - Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter